Welcome to our dedicated page for Nukkleus SEC filings (Ticker: NUKK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
T3 Defense Inc. filings document material-event disclosures for a Nasdaq-listed emerging growth company with common stock and warrants registered on Nasdaq. The 8-K record covers operating and financial results, backlog disclosures, capital-structure transactions such as note exchanges, and security-structure matters involving common stock and warrants.
Filings also document Nasdaq continued-listing notices, governance and insider agreement disclosures, and public-company reporting topics tied to listing compliance and capital structure.
Anastasiia Kotaieva, a director and 10% owner of Nukkleus Inc. (NUKK), reported multiple cashless warrant exercises that materially increased her indirect holdings. On 10/08/2025 and 10/09/2025 she acquired a total of 1,377,421 common shares via cashless exercises and related assignments, bringing her reported indirect beneficial ownership to 1,847,373 shares. The filing also shows a previously exercised pre-funded warrant reassigned on 10/07/2025 and remaining derivative positions that convert into common stock through warrants with various strike prices and expirations through 08/11/2030. The transactions are reported on Form 4 and reflect internal ownership changes via warrant exercises rather than open-market purchases.
Nukkleus Inc. reported that Nasdaq's Listing Qualifications Department confirmed the company has regained compliance with the minimum market value of listed securities requirement under Nasdaq Listing Rule 5450(b)(2)(A). The company said this matter is closed following that written confirmation. The filing identifies common stock (ticker NUKK) and warrants (ticker NUKKW) listed on The Nasdaq Stock Market and includes a press release dated September 29, 2025. The report is signed by Chief Executive Officer Menachem Shalom.
Nukkleus Inc. filed an 8-K reporting the execution of a Common Stock Purchase Agreement and a Registration Rights Agreement with Esousa Group Holdings, LLC, both dated September 19, 2025. The filing lists a related press release dated September 19, 2025 and includes a signed cover page by Menachem Shalom, Chief Executive Officer. The listed exhibits indicate a transaction and accompanying registration mechanics were agreed the same day, and the company provided interactive XBRL cover-page data.
The filing text is brief and focuses on the existence and dates of the agreements and press release; it does not disclose deal economics, share counts, consideration, or other financial terms, so material financial impacts are not specified within this document.
Nukkleus Inc. filed a Form D for a Regulation D, Rule 506(b) offering of units (each unit: Series A Convertible Preferred Stock plus a common warrant to purchase 1.5 shares). The stated total offering size was $10,000,000, of which $10,000,000 has been sold and $0 remains. The minimum outside investment is $50,000. Sales commissions are estimated at $700,000 and the placement agent is Dawson James Securities, Inc. The issuer identifies its jurisdiction as Delaware, principal place of business at 575 Fifth Ave, New York, NY, and classifies itself in "Other Technology." Proceeds are to be used for working capital and to acquire Tiltan Software Engineering Ltd. and Star 26 Capital Inc. The CEO and director, Menachem Shalom, is an officer/director and controlling shareholder of Star 26 Capital Inc. The filing reports 2 investors and indicates the offering is not intended to last more than one year.
Nukkleus Inc. filed an 8-K reporting a material agreement. The filing lists an Amended and Restated Securities Purchase Agreement and Call Option dated September 15, 2025 among Nukkleus Inc., Star 26 Capital Inc., the shareholders of Star 26 Capital Inc. and Menachem Shalom as representative. The filing also includes a Press Release dated September 16, 2025 as an exhibit and states common stock (NUKK) and warrants (NUKKW) trade on The Nasdaq Stock Market. The document is signed by Menachem Shalom, Chief Executive Officer.